Multiple Myeloma Coverage from Every Angle

Shaji Kumar, MD, and Prashant Kapoor, MD: Update on CAR T-Cell Therapies for Multiple Myeloma

Posted: Wednesday, September 2, 2020

Shaji Kumar, MD, and Prashant Kapoor, MD, both of the Mayo Clinic, discuss results from three abstracts on B-cell maturation antigen–targeted CAR T-cell therapies for relapsed and refractory multiple myeloma: the KarMMa study on idecabtagene vicleucel; an update of the phase I/II EVOLVE trial of orvacabtagene autoleucel; and CARTITUDE-1, a phase Ib/II study of JNJ-4528.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.